Connect with us
A VHIR–VHIO study developed ImmunoPET, a PET-based “virtual biopsy” using a radiolabeled antibody to detect LIF in glioblastoma. It noninvasively maps tumor heterogeneity, identifies patients suited...
Of the total amount that Laminar Pharma estimates it needs, $10.7 million (€10 million) correspond to bank financing already agreed with Banca March. In addition, the...
Cancer patients now have options, aside from chemotherapy, such as liquid biopsy, immunotherapy and glioblastoma treatment.